Transthoracic lung biopsy (TLB) provides a histological diagnosis of nodule or lung mass. Pneumothorax is the main complication of TLB with an average of 20%. Many risk factors, whether clinical, computed tomography or related to TLB, are described in the literature. The British Thoracic Society recommends monitoring for 2 hours after the procedure with a possible discharge if the chest X-ray is normal. There is no French or European recommendation for monitoring the occurrence of pneumothorax after TLB. In the university center of Besançon, France, a minimum supervision of 4 hours is recommended and approximately one in two patients is hospitalized until the following day to reach this minimum time of 4 hours. The objective of the SPOT study is to perform a predictive score of pneumothorax from a retrospective cohort of patients for whom a transthoracic lung biopsy was performed and to validate this score on a prospective cohort. The expected goal is to select patients who can benefit from outpatient care by shortening the post-procedure surveillance period and to monitor more long-term only high-risk patients.
Study Type
OBSERVATIONAL
Enrollment
1,000
Needle lung biopsy
CHU Besançon
Besançon, Doubs, France
RECRUITINGPneumothorax occurrence
Pneumothorax is defined by the observation on the chest x-ray of a pleural detachment regardless of its importance.
Time frame: between 4 and 24 hours after procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.